COVID-19 prevention efforts reduced mortality among residents with dementia
By
Kimberly Bonvissuto
Aug 29, 2023
After increasing “substantially” during the first year of the COVID-19 pandemic, dementia-related deaths declined in the second year, likely due to vaccination and prevention efforts in long-term care...
When it comes to virtual reality, imagination often trumps innovation, research finds
By
Aaron Dorman
Aug 28, 2023
When it comes to virtual reality, programming advances in the tech may not be as important to users as what they bring themselves: their imagination.
Operational design for a dementia-focused future
By
Mimi DeVinney
Aug 28, 2023
An increasing number of providers of services for seniors will be required to serve people with dementia and their caregivers across all levels of care. Aligning all facets of operations to serve this...
Speech therapy giant expands access for seniors via telehealth partnership
By
Aaron Dorman
Aug 25, 2023
A new partnership between a speech therapy platform and a telehealth provider will expand offerings of speech therapy programs for seniors.
More news for Thursday, Aug. 24
By
Kimberly Bonvissuto
Aug 24, 2023
Watermark Retirement Communities earns ‘High Performer’ status in HRC-SAGE LEI … Older adults fastest-growing cannabis clientele … Routine vaccines can cut risk for later Alzheimer’s disease...
Routine vaccines can cut risk for later Alzheimer’s disease
Aug 23, 2023
The findings were seen for tetanus and diphtheria, shingles and pneumococcus vaccines.
Certain types of air pollution raise risk of dementia: study
By
Kimberly Bonvissuto
Aug 22, 2023
The risk of dementia is greater among people in regions of the US with high levels of a certain type of air pollution, particularly from agriculture and wildfires, according to a new study published in...
Correlates of divorce/separation examined in seniors with dementia
Aug 18, 2023
Divorce/separation was less likely at later stages of dementia and more likely with more severe neuropsychiatric behavioral symptoms.
Eligibility limited for anti-β amyloid mAbs in seniors with MCI
Aug 18, 2023
Few older adults with mild cognitive impairment or mild dementia were eligible for lecanemab or aducanumab after applying clinical trial criteria.
More news for Friday, Aug. 18
By
Kimberly Bonvissuto
Aug 18, 2023
Satellite campuses a common growth strategy for senior living providers … AI may be the future of senior care … Few older adults may qualify for new Alzheimer’s drugs: study … Family counseling...